International regulators collaborate on generics

The European Union is taking the lead on a three-year project aimed at speeding up the assessment of generic drug applications. The International Generic Drug Regulators Pilot (IGDRP) has been set up in a bid to increase the amount of information which international authorities share in the pre-market review of generics. This move is driven by what the EU says are mounting pressures on health regulatory authorities “due to increasing workloads and risks associated with complex global supply chains”.  


Read the source article at

About the Author

Leave a Reply